Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Holist Nurs Pract ; 28(3): 164-70, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24722611

RESUMO

This study examined the concomitant use of 2 complementary and alternative medicine modalities, Healing Harp and Healing Touch, to reduce pain, anxiety, and nausea in the postoperative patient population. The results demonstrate the effectiveness of using concomitant Healing Touch and Healing Harp to significantly reduce moderate to severe pain and anxiety in this patient population. Further research is warranted.


Assuntos
Musicoterapia , Manejo da Dor/métodos , Toque Terapêutico , Feminino , Saúde Holística , Humanos , Pacientes Internados , Medição da Dor , Ensaios Clínicos Controlados Aleatórios como Assunto , Estudos Retrospectivos , Estatísticas não Paramétricas
2.
Clin Infect Dis ; 46 Suppl 3: S195-203, 2008 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-18284359

RESUMO

After the 2001 anthrax bioterror attacks, the Centers for Disease Control and Prevention developed an algorithm to evaluate patients rapidly for suspected smallpox. A prospective, multicenter study examined the performance of this algorithm in assessing patients with an acute, generalized vesicular or pustular rash (AGVPR) admitted to emergency departments and inpatient units of 12 acute-care hospitals in 6 states. Of 26,747 patients (3.5% of all admissions) with rashlike conditions screened, 89 (1.2 patients per 10,000 admissions) had an AGVPR. Physicians or study staff classified none of 73 enrolled patients as being at high risk for having smallpox; 72 (99%) were classified as being at low risk, and 1 was classified as being at moderate risk. The discharge diagnosis for 55 (75%) of these 73 participants was varicella illness. Use of the algorithm did not result in misclassification of AGVPR as high risk for smallpox. The algorithm is a highly specific tool for clinical evaluation of suspected smallpox disease.


Assuntos
Algoritmos , Planejamento em Desastres , Surtos de Doenças/prevenção & controle , Exantema/virologia , Varíola/diagnóstico , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Criança , Pré-Escolar , Diagnóstico Diferencial , Exantema/etiologia , Feminino , Humanos , Lactente , Masculino , Auditoria Médica , Pessoa de Meia-Idade , Estudos Prospectivos , Estados Unidos
3.
J Infect Dis ; 199(3): 391-7, 2009 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-19090774

RESUMO

BACKGROUND: Oral poliovirus vaccine (OPV) has not been used in the United States since 2000. Type 1 vaccine-derived poliovirus (VDPV) was identified in September 2005, from an unvaccinated Amish infant hospitalized in Minnesota with severe combined immunodeficiency. An investigation was conducted to determine the source of the virus and its means of transmission. METHODS: The infant was tested serially for poliovirus excretion. Investigations were conducted to detect poliovirus infections or paralytic poliomyelitis in Amish communities in Minnesota, neighboring states, and Ontario, Canada. Genomic sequences of poliovirus isolates were determined for phylogenetic analysis. RESULTS: No source for the VDPV could be identified. In the index community, 8 (35%) of 23 children tested, including the infant, had evidence of type 1 poliovirus or VDPV infection. Phylogenetic analysis suggested that the VDPV circulated in the community for approximately 2 months before the infant's infection was detected and that the initiating OPV dose had been given before her birth. No paralytic disease was found in the community, and no poliovirus infections were found in other Amish communities investigated. CONCLUSIONS: This is the first demonstrated transmission of VDPV in an undervaccinated community in a developed country. Continued vigilance is needed in all countries to identify poliovirus infections in communities at high risk of poliovirus transmission.


Assuntos
Poliomielite/transmissão , Vacinas contra Poliovirus/administração & dosagem , Poliovirus/classificação , Poliovirus/isolamento & purificação , Imunodeficiência Combinada Severa/complicações , Adolescente , Sequência de Aminoácidos , Antígenos Virais/química , Antígenos Virais/genética , Transplante de Medula Óssea , Pré-Escolar , Fezes/virologia , Feminino , Humanos , Imunoglobulinas Intravenosas/uso terapêutico , Lactente , Minnesota , Filogenia , Poliomielite/prevenção & controle , Poliomielite/virologia , Poliovirus/genética , Vacinas contra Poliovirus/imunologia , Imunodeficiência Combinada Severa/terapia , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA